Pegylation of recombinant blood coagulation factors in the presence of bound antibodies

Details for Australian Patent Application No. 2009303368 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Mitterer, Artur; Graninger, Michael; Hasslacher, Meinhard

Agent Cullens

Pub. Number AU-B-2009303368

PCT Pub. Number WO2010/045321

Priority 61/105,548 15.10.08 US

Filing date 14 October 2009

Wipo publication date 22 April 2010

Acceptance publication date 5 April 2012

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/045321 Priority application(s): WO2010/045321

5 April 2012 Application Accepted

  Published as AU-B-2009303368

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009303380-Gaming system having virtual assets and achievements

2009303355-FAS/FASL or other death receptor targeted methods and compositions for killing tumor cells